Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)

医学 多发性骨髓瘤 内科学 累积发病率 移植 来那度胺 造血干细胞移植 临床终点 肿瘤科 多元分析 外科 临床试验
作者
Laurent Garderet,Luuk Gras,Linda Köster,Laurien Baaij,Nada Hamad,Anita D’Souza,Noel Estrada‐Merly,Parameswaran Hari,Wael Saber,Andrew J. Cowan,Minako Iida,Shinichiro Okamoto,Hiroyuki Takamatsu,Shohei Mizuno,Koji Kawamura,Yoshihisa Kodera,Bor‐Sheng Ko,Christopher Liam,Kim Wah Ho,A. Sim Goh
出处
期刊:American Journal of Hematology [Wiley]
卷期号:99 (11): 2084-2095 被引量:3
标识
DOI:10.1002/ajh.27451
摘要

Autologous hematopoietic cell transplantation (AHCT) is a commonly used treatment in multiple myeloma (MM). However, real-world global demographic and outcome data are scarce. We collected data on baseline characteristics and outcomes from 61 725 patients with newly diagnosed MM who underwent upfront AHCT between 2013 and 2017 from nine national/international registries. The primary endpoint was overall survival (OS), and the secondary endpoints were progression-free survival (PFS), relapse incidence (RI) and non-relapse mortality (NRM). Median OS amounted to 90.2 months (95% CI 88.2-93.6) and median PFS 36.5 months (95% CI 36.1-37.0). At 24 months, cumulative RI was 33% (95% CI 32.5%-33.4%) and NRM was 2.5% (95% CI 2.3%-2.6%). In the multivariate analysis, superior outcomes were associated with younger age, IgG subtype, complete hematological response at auto-HCT, Karnofsky score of 100%, international staging scoring (ISS) stage 1, HCT-comorbidity index (CI) 0, standard cytogenetic risk, auto-HCT in recent years, and use of lenalidomide maintenance. There were differences in the baseline characteristics and outcomes between registries. While the NRM was 1%-3% at 12 months worldwide, the OS at 36 months was 69%-84%, RI at 12 months was 12%-24% and PFS at 36 months was 43%-63%. The variability in these outcomes is attributable to differences in patient and disease characteristics as well as the use of maintenance and macroeconomic factors. In conclusion, worldwide data indicate that AHCT in MM is a safe and effective therapy with an NRM of 1%-3% with considerable regional differences in OS, PFS, RI, and patient characteristics. Maintenance treatment post-AHCT had a beneficial effect on OS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小星星发布了新的文献求助10
刚刚
刚刚
刚刚
Alinse完成签到,获得积分10
1秒前
kkkkk完成签到 ,获得积分10
1秒前
jx发布了新的文献求助10
1秒前
1秒前
水水的完成签到 ,获得积分10
1秒前
1秒前
所所的应助被tong采纳,获得10
1秒前
TT完成签到,获得积分20
1秒前
Bob完成签到,获得积分10
1秒前
2秒前
ding的应助被眼睛大的文龙采纳,获得10
2秒前
胡萝贝完成签到,获得积分10
2秒前
Frank完成签到,获得积分0
3秒前
3秒前
3秒前
liang完成签到 ,获得积分10
4秒前
wyuan发布了新的文献求助10
4秒前
喔喔某人发布了新的文献求助10
4秒前
4秒前
草根努力记完成签到 ,获得积分10
4秒前
5秒前
lx举报JACS的求助涉嫌违规
5秒前
小鞠佩奇完成签到,获得积分20
6秒前
思源的应助被花05采纳,获得10
6秒前
thyee完成签到,获得积分10
7秒前
7秒前
年糕发布了新的文献求助10
8秒前
10秒前
11秒前
11秒前
11秒前
chillax发布了新的文献求助30
11秒前
12秒前
SciGPT的应助被霁星河采纳,获得10
12秒前
周lm完成签到,获得积分10
13秒前
13秒前
Chw完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163664
求助须知:如何正确求助?哪些是违规求助? 9557817
关于积分的说明 21741980
捐赠科研通 7754358
什么是DOI,文献DOI怎么找? 3428338
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472943